Nitracaine

Source: Wikipedia, the free encyclopedia.
Nitracaine
Legal status
Legal status
Identifiers
  • (3-Diethylamino-2,2-dimethylpropyl)-4-nitrobenzoate
JSmol)
  • CCN(CC)CC(C)(C)COC(=O)C1=CC=C(C=C1)[N+](=O)[O-]
  • InChI=1S/C16H24N2O4/c1-5-17(6-2)11-16(3,4)12-22-15(19)13-7-9-14(10-8-13)18(20)21/h7-10H,5-6,11-12H2,1-4H3
  • Key:SPTIETJWCCCJSE-UHFFFAOYSA-N

Nitracaine is a synthetic compound classified as a local anesthetic with stimulant properties. It falls into the class of drugs known as local anesthetics, and it is chemically related to cocaine. Nitracaine shares some similarities in effects with cocaine but has its own distinct pharmacological profile. The chemical structure of nitracaine consists of a benzoic acid ester with a para-substituted phenyl ring. It is formally known as 3-(diethylamino)-2,2-dimethylpropyl 4-nitrobenzoate. The presence of the nitro group (NO2) in its molecular structure contributes to its anesthetic properties. [1][2][3]

It is closely related to dimethocaine.

Legal status

Sweden's public health agency suggested classifying Nitracaine as a hazardous substance, on September 25, 2019.[4]

See also

References

  1. PMID 24574100
    .
  2. .
  3. ^ "Nitracaine". New Synthetic Drugs Database. 12 November 2023.
  4. ^ "Tretton ämnen föreslås klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 25 September 2019. Archived from the original on 31 October 2019. Retrieved 11 November 2019.